Search hospitals
>
Minnesota
>
Minneapolis
Minneapolis VA Health Care System, Minneapolis, MN
Claim this profile
Minneapolis, Minnesota 55417
Global Leader in Lung Cancer
Global Leader in Post-Traumatic Stress Disorder
Conducts research for Prostate Cancer
Conducts research for Colorectal Cancer
Conducts research for Leukemia
391 reported clinical trials
30 medical researchers
Summary
Minneapolis VA Health Care System, Minneapolis, MN is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Colorectal Cancer, Leukemia and other specialties. Minneapolis VA Health Care System, Minneapolis, MN is involved with conducting 391 clinical trials across 425 conditions. There are 30 research doctors associated with this hospital, such as Santiago Garcia, MD, Mark A. Klein, Sharon D. Luikart, and Kelvin Lim, MD.
Area of expertise
Lung Cancer
Minneapolis VA Health Care System, Minneapolis, MN has run 42 trials for Lung Cancer. Some of their research focus areas include:
Post-Traumatic Stress Disorder
Minneapolis VA Health Care System, Minneapolis, MN has run 35 trials for Post-Traumatic Stress Disorder.
Top PIs
Santiago Garcia, MD
The Christ Hospital
8 years of reported clinical research
Mark A. Klein
Minneapolis VA Medical Center
7 years of reported clinical research
Sharon D. Luikart
Minneapolis VA Medical Center
7 years of reported clinical research
Kelvin Lim, MD
University of Minnesota
4 years of reported clinical research
Clinical Trials running at Minneapolis VA Health Care System, Minneapolis, MN
Lung Cancer
Post-Traumatic Stress Disorder
Prostate Cancer
Cancer
Non-Small Cell Lung Cancer
Parkinson's Disease
Bipolar Disorder
Heart Failure
Chronic Obstructive Pulmonary Disease
Obesity
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Minneapolis VA Health Care System, Minneapolis, MN?
Minneapolis VA Health Care System, Minneapolis, MN is a medical facility located in Minneapolis, Minnesota. This center is recognized for care of Lung Cancer, Post-Traumatic Stress Disorder, Prostate Cancer, Colorectal Cancer, Leukemia and other specialties. Minneapolis VA Health Care System, Minneapolis, MN is involved with conducting 391 clinical trials across 425 conditions. There are 30 research doctors associated with this hospital, such as Santiago Garcia, MD, Mark A. Klein, Sharon D. Luikart, and Kelvin Lim, MD.
Where is Minneapolis VA Health Care System, Minneapolis, MN located?
The Minneapolis VA Health Care System is situated at One Veterans Drive, Minneapolis, MN 55417. For directions from St. Paul, take 35E South to the West 7th Street/State Route 5 exit, then follow signs for U.S. 55 West and Fort Snelling. For customized driving directions, consider using Google Maps or Waze.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at the Minneapolis VA Health Care System, patients can contact the billing and insurance department directly. The main contact number is 612-725-2000, with a toll-free option available at 866-414-5058. Additionally, for assistance with care or resolving issues, a patient advocate can be reached for support.
What insurance does Minneapolis VA Health Care System, Minneapolis, MN accept?
The Minneapolis VA Health Care System in Minneapolis, MN, primarily serves veterans through insurance plans provided by the Department of Veterans Affairs (VA), covering health, support, and facility services in Minnesota and western Wisconsin. Veterans receiving care here benefit from no copays for essential services including X-rays, lab tests, and preventative care. Additionally, the VA offers health insurance for its employees, with premiums partially subsidized.
What awards or recognition has Minneapolis VA Health Care System, Minneapolis, MN received?
The Minneapolis VA Health Care System is renowned for its extensive research program, featuring over 150 investigators and more than 500 projects funded by various prestigious sources. It boasts affiliations with the University of Minnesota and has earned accolades for innovations such as the Habit Camera, Wand-based camera, and its unique approaches to mental health treatment. Additionally, the hospital houses four major research centers and is an active participant in numerous national research initiatives.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.